Last Week in GER Research: Haidilao, Xiaomi, Ping An, 111, Qutoutiao, Nio and Tesla
Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a differentiated...
349 Views
Ascletis Pharma: Invalidation of Gilead Patents Won't Help
China's State Intellectual Property Office (SIPO) last week invalidated Gilead Sciences (GILD US) 's patent claims on the base compound for...
805 Views
Last Week in GER Research: Tesla, Pinduoduo, Beigene, Koolearn, Pintec, STX and China Tower
Below is a recap of the key research produced by the Global Equity Research team. This week we highlight some detailed math on a potential Tesla...
321 Views
BeiGene (6160 HK): On a Stronger Post-Listing Footing than Ascletis
Hong Kong investors have had their first taste of biotech stocks with the recent listings of Ascletis Pharma Inc (1672 HK) and BeiGene Ltd (6160...
395 Views
ECM Coverage Weekly Update (11 August 2018)
Aequitas Research puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. It has been a fairly quiet...
473 Views